Total raised
$1.1M
Last: Pre-Seed 2022-12
Stage
Pre-Seed
Founded
2022
Headcount
4
HQ
Nazareth
Sector
Health Tech & Life Sciences
About
Dio Tree develops a novel small molecule for the treatment of ovarian cancer. The technology is based on inhibition of the enzyme DIO3, which is a major driver in many types of cancer, specifically ovarian cancer. The technology involves a series of small molecules targeting DIO3.
Funding history · 1 round · $1.1M total
2022-12
Pre-Seed
$400K
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcarePatientsLife SciencesBiotechnology
Business model
B2B2C
Tags
healthcareoncologycancerfemtechbiotechnologywomen-healthbiopharmaceutical